Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Seres Therapeutics Inc (MCRB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Seres Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.9199 -0.0045    -0.49%
17/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.8860
-0.0339
-3.6852%
19:52:40 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,979,435
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.9010 - 0.9985
Seres Therapeutics Inc 0.9199 -0.0045 -0.49%

MCRB Recent Sentiments

 
This page contains information on users’ sentiments for the Seres Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 17, 2024 Lucy Borboleta   0.9200 -0.01%
May 16, 2024 Lucy Borboleta   0.9131 May 17, 2024 @ 0.9203 +0.79%
May 15, 2024 Lucy Borboleta   0.9490 May 16, 2024 @ 0.9190 -3.16%
May 15, 2024 Lucy Borboleta   0.9899 May 15, 2024 @ 0.9476 -4.27%
May 15, 2024 Lucy Borboleta   0.9480 May 15, 2024 @ 0.9899 +4.42%
May 15, 2024 Lucy Borboleta   0.9350 May 15, 2024 @ 0.9450 +1.07%
May 14, 2024 Lucy Borboleta   0.8930 May 15, 2024 @ 0.9450 +5.82%
May 14, 2024 Lucy Borboleta   0.8859 May 14, 2024 @ 0.8930 +0.80%
May 14, 2024 Lucy Borboleta   0.8802 May 14, 2024 @ 0.8859 +0.65%
May 14, 2024 Lucy Borboleta   0.9300 May 14, 2024 @ 0.8802 -5.35%
May 14, 2024 Lucy Borboleta   0.9205 May 14, 2024 @ 0.9300 +1.03%
May 14, 2024 Lucy Borboleta   0.9468 May 14, 2024 @ 0.9270 -2.09%
May 10, 2024 Ersin Erdem   1.0700 -14.03%
May 09, 2024 Lucy Borboleta   1.0250 May 14, 2024 @ 0.9468 -7.63%
May 09, 2024 Carlos Huacoto   1.0100 -8.92%
May 09, 2024 Robbert Kuipers   1.0250 -10.25%
May 09, 2024 Robbert Kuipers   1.0200 May 09, 2024 @ 1.0200 0.00%
May 09, 2024 Lucy Borboleta   1.0110 May 09, 2024 @ 1.0250 +1.38%
May 08, 2024 Pablo Llorca   0.7572 May 13, 2024 @ 1.0600 +39.99%
May 08, 2024 Ni Tefe   0.7667 May 08, 2024 @ 0.7667 0.00%
May 08, 2024 saleh almutairi   0.7667 +19.98%
May 08, 2024 Ömer Faruk Şahbaz   0.7700 May 13, 2024 @ 1.0600 +37.66%
May 08, 2024 Mike Em   1.0310 May 13, 2024 @ 1.0600 +2.81%
May 06, 2024 Lucy Borboleta   1.1903 May 09, 2024 @ 1.0110 -15.06%
May 06, 2024 Lucy Borboleta   1.1300 May 06, 2024 @ 1.1950 +5.75%
May 06, 2024 Lucy Borboleta   1.1301 May 06, 2024 @ 1.1301 0.00%
May 03, 2024 Lucy Borboleta   1.1150 May 06, 2024 @ 1.1392 +2.17%
May 03, 2024 Sri Kiran   1.1058 +16.81%
May 03, 2024 enrico gazzato   1.1000 -16.37%
May 03, 2024 Lucy Borboleta   1.1250 May 03, 2024 @ 1.1150 -0.89%
May 03, 2024 Gian luigi Gori   1.1293 -18.54%
May 02, 2024 Lucy Borboleta   1.0800 May 03, 2024 @ 1.1100 +2.78%
May 02, 2024 Lucy Borboleta   1.0650 May 02, 2024 @ 1.0800 +1.41%
May 02, 2024 Lucy Borboleta   1.0250 May 02, 2024 @ 1.0699 +4.38%
May 01, 2024 Mike Em   0.9950 May 06, 2024 @ 1.1750 +18.09%
Apr 30, 2024 Lucy Borboleta   0.9950 May 02, 2024 @ 1.0800 +8.54%
Apr 30, 2024 Lucy Borboleta   0.9901 Apr 30, 2024 @ 0.9950 +0.49%
Apr 30, 2024 Lucy Borboleta   0.9922 Apr 30, 2024 @ 0.9900 -0.22%
Apr 30, 2024 Lucy Borboleta   0.9780 Apr 30, 2024 @ 0.9936 +1.60%
Apr 30, 2024 Lucy Borboleta   0.9199 Apr 30, 2024 @ 0.9710 +5.55%
Apr 29, 2024 Lucy Borboleta   0.9004 Apr 30, 2024 @ 0.9090 +0.96%
Apr 29, 2024 Lucy Borboleta   0.8860 Apr 29, 2024 @ 0.9004 +1.63%
Apr 26, 2024 Lucy Borboleta   0.8005 Apr 29, 2024 @ 0.8860 +10.68%
Apr 25, 2024 Lucy Borboleta   0.8098 Apr 26, 2024 @ 0.7427 -8.29%
Apr 24, 2024 Lucy Borboleta   0.7096 Apr 25, 2024 @ 0.8098 +14.12%
Apr 24, 2024 Lucy Borboleta   0.7574 Apr 24, 2024 @ 0.7046 -6.97%
Apr 24, 2024 Lucy Borboleta   0.7599 Apr 24, 2024 @ 0.7573 -0.34%
Apr 23, 2024 Lucy Borboleta   0.7446 Apr 24, 2024 @ 0.7599 +2.05%
Apr 23, 2024 Lucy Borboleta   0.7401 Apr 23, 2024 @ 0.7446 +0.61%
Apr 23, 2024 Lucy Borboleta   0.7455 Apr 23, 2024 @ 0.7401 -0.72%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MCRB Comments

Write your thoughts about Seres Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sri Kiran
Sri Kiran May 03, 2024 11:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sorry over valued zone. Not oversold.
Sri Kiran
Sri Kiran May 03, 2024 11:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Quickly burning its cash and also in oversold zone.
Ivan Dujic
Ivan Dujic Apr 27, 2023 3:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In December 2020, when SER-109 passed phase 3, the price rose to $38. Expect it to be at that price again in a month. Analysts will increase the target price after FDA approval.
Szoka Krisztian
Szoka Krisztian Jul 22, 2021 2:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They develop a new placebo... Great... Trash
sas stas
sas stas Aug 14, 2020 10:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
excellent move.
Fred Taylor
Fred Taylor Aug 10, 2020 5:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Which 1 is moving up like this 1 tomorrow
Anthony Meunier
Anthony Meunier Aug 10, 2020 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hopefully not another kodak
derek carlson
derek carlson Aug 10, 2020 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Overnight skyrocket for no reason, terrible Financials? I'd say so.
sas stas
sas stas Aug 10, 2020 11:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
come to daddy
sas stas
sas stas Aug 10, 2020 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lets find a good entry point
Hya Laurent
Hya Laurent Aug 10, 2020 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
shares were halted ?
Mick West
googleMickWest Aug 10, 2020 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
several times already
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email